Search

everythinglearnresearchcommunity

for

Search:↓

Overexpressing PKCα in mice skin increases inflammation but doesn't affect tumor growth.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

The combination therapy was effective and well-tolerated, especially in young patients.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Mechanical tension worsens keloid scars by activating inflammation and fibrosis pathways.

Human thymus has stem cells that can self-renew and maintain their identity.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

Calancardin B may help reduce inflammation in immune cells.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

The hamster polyomavirus middle T antigen is linked to tumors in hamsters and associates with a specific tyrosine kinase.

The treatment combination is effective and generally safe for lung cancer.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Clonally expanded CD8+ T cells cause alopecia areata.

Hoxc8 gene helps start mammary gland development by controlling specific signals.

17β-estradiol can reduce inflammation in the skin.

A new therapy for a skin blistering condition has not been developed yet.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

Dimethylarsinic acid speeds up skin tumor growth in certain mice.